These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 24849726

  • 1. Suppression of oxidative stress and 5-lipoxygenase activation by edaravone improves depressive-like behavior after concussion.
    Higashi Y, Hoshijima M, Yawata T, Nobumoto A, Tsuda M, Shimizu T, Saito M, Ueba T.
    J Neurotrauma; 2014 Oct 15; 31(20):1689-99. PubMed ID: 24849726
    [Abstract] [Full Text] [Related]

  • 2. Attenuation of axonal injury and oxidative stress by edaravone protects against cognitive impairments after traumatic brain injury.
    Ohta M, Higashi Y, Yawata T, Kitahara M, Nobumoto A, Ishida E, Tsuda M, Fujimoto Y, Shimizu K.
    Brain Res; 2013 Jan 15; 1490():184-92. PubMed ID: 22982593
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sodium Phenylbutyrate and Edaravone Abrogate Chronic Restraint Stress-Induced Behavioral Deficits: Implication of Oxido-Nitrosative, Endoplasmic Reticulum Stress Cascade, and Neuroinflammation.
    Jangra A, Sriram CS, Dwivedi S, Gurjar SS, Hussain MI, Borah P, Lahkar M.
    Cell Mol Neurobiol; 2017 Jan 15; 37(1):65-81. PubMed ID: 26886752
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Edaravone abrogates LPS-induced behavioral anomalies, neuroinflammation and PARP-1.
    Sriram CS, Jangra A, Gurjar SS, Mohan P, Bezbaruah BK.
    Physiol Behav; 2016 Feb 01; 154():135-44. PubMed ID: 26522738
    [Abstract] [Full Text] [Related]

  • 9. Edaravone, a free radical scavenger, protects neuronal cells' mitochondria from ischemia by inactivating another new critical factor of the 5-lipoxygenase pathway affecting the arachidonic acid metabolism.
    Song Y, Bei Y, Xiao Y, Tong HD, Wu XQ, Chen MT.
    Brain Res; 2018 Jul 01; 1690():96-104. PubMed ID: 29551652
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The free radical scavenger edaravone rescues rats from cerebral infarction by attenuating the release of high-mobility group box-1 in neuronal cells.
    Kikuchi K, Kawahara K, Tancharoen S, Matsuda F, Morimoto Y, Ito T, Biswas KK, Takenouchi K, Miura N, Oyama Y, Nawa Y, Arimura N, Iwata M, Tajima Y, Kuramoto T, Nakayama K, Shigemori M, Yoshida Y, Hashiguchi T, Maruyama I.
    J Pharmacol Exp Ther; 2009 Jun 01; 329(3):865-74. PubMed ID: 19293391
    [Abstract] [Full Text] [Related]

  • 12. Striatal neuroprotection from neonatal hypoxia-ischemia in piglets by antioxidant treatment with EUK-134 or edaravone.
    Ni X, Yang ZJ, Carter EL, Martin LJ, Koehler RC.
    Dev Neurosci; 2011 Jun 01; 33(3-4):299-311. PubMed ID: 21701140
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain.
    Zhang N, Komine-Kobayashi M, Tanaka R, Liu M, Mizuno Y, Urabe T.
    Stroke; 2005 Oct 01; 36(10):2220-5. PubMed ID: 16166574
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Edaravone attenuates brain edema and neurologic deficits in a rat model of acute intracerebral hemorrhage.
    Nakamura T, Kuroda Y, Yamashita S, Zhang X, Miyamoto O, Tamiya T, Nagao S, Xi G, Keep RF, Itano T.
    Stroke; 2008 Feb 01; 39(2):463-9. PubMed ID: 18096835
    [Abstract] [Full Text] [Related]

  • 19. [Pharmacological and clinical profile of the free radical scavenger edaravone as a neuroprotective agent].
    Tanaka M.
    Nihon Yakurigaku Zasshi; 2002 May 01; 119(5):301-8. PubMed ID: 12061142
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.